These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11210769)

  • 1. [COX-2--what are the clinical implications?].
    Lipsky PE
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):679-82. PubMed ID: 11210769
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
    Lipsky PE; Abramson SB; Breedveld FC; Brook P; Burmester R; Buttgereit F; Cannon GW; Catella-Lawson F; Crofford LJ; Doherty M; Dougados M; DuBois RN; Froelich J; Garcia Rodriguez LA; Gibofsky A; Hernandez-Diaz S; Hochberg MC; Krause A; Liang MH; Machold K; Peloso PM; Raisz LG; Schayes B; Scheiman JM; Simon LS; Smolen J
    J Rheumatol; 2000 Jun; 27(6):1338-40. PubMed ID: 10852251
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S; Crofford LJ
    Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis treatment update.
    Johns Hopkins Med Lett Health After 50; 2000 Jan; 11(11):3. PubMed ID: 10614184
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
    MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
    [No Abstract]   [Full Text] [Related]  

  • 8. Arthritis. Timely treatments for an ageless disease.
    Lewis C
    FDA Consum; 2000; 34(3):27-9, 31-3. PubMed ID: 11521251
    [No Abstract]   [Full Text] [Related]  

  • 9. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F; Harrell K; Fischer R
    South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COX-2 inhibitor to whom?].
    Martio J
    Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
    [No Abstract]   [Full Text] [Related]  

  • 12. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D
    MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 14. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
    Pascucci RA
    J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2-selective inhibition: a new advance in pain management. Chairman's introduction.
    Korttila K
    Eur J Anaesthesiol Suppl; 2002; 25():1-2. PubMed ID: 12449671
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
    Davis P; Juby A; Robertson S; Richard N
    J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safe use of anti-inflammatory analgesics].
    Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
    Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.